Increased plasma concentrations of Palmitoylethanolamide, an endogenous fatty acid amide, affect oxidative damage of human low-density lipoproteins: An in vitro study
Abstract
Fatty acid ethanolamides (NAEs) are naturally occurring hydrophobic molecules usually present in a very small amount in many mammalian tissues and cells. Moreover, these compounds have been isolated in mammalian biological fluids, such as blood. Palmitoylethanolamide (C16:0) (PEA) is a fully saturated NAE, which presents some possible pharmaceutical activities, such as anti-inflammatory and antinociceptive effects.
PEA is physiologically present in the mammalian blood at concentrations ranging from 9.4 to 16.7
pmol/ml.
Since increasing evidence indicates that oxidative modification of low-density lipoproteins (LDL) is an important determinant in atherogenesis, the aim of this study was to evaluate the effect of physiologically relevant concentrations of PEA on Cu2+-induced LDL oxidation (measured as conjugated dienes formation). Our experiments indicate both anti-oxidative and slightly pro-oxidative effects of PEA. The anti-oxidative effect is obtained at low PEA concentrations (0.01 and 0.1
μM), while the pro-oxidative effect is obtained at a higher PEA concentration (1
μM). Fluorescence and circular dichroism data indicate that the effect of PEA occurs mainly by affecting the conformational features of ApoB-100.
Abbreviations: NAE, fatty acid ethanolamides, PEA, palmitoylethanolamide, LDL, low-density lipoproteins, Laurdan, 2-dimethylamino-(6-lauroyl)-naphtalene, GP, generalised polarization, CD, circular dichroism, AEA, anandamide
Keywords: Palmitoylethanolamide, LDL, Copper, Lipid peroxidation, Tryptophan oxidation, Fluorescence
To access this article, please choose from the options below
PII: S0021-9150(05)00121-8
doi:10.1016/j.atherosclerosis.2005.01.043
© 2005 Elsevier Ireland Ltd. All rights reserved.
